Evidence map›Paper›PMID 33250895›Full record

Observational studyFrontiers in immunology2020

Systems Biology Methods Applied to Blood and Tissue for a Comprehensive Analysis of Immune Response to Hepatitis B Vaccine in Adults.

Rym Ben-Othman, Bing Cai, Aaron C Liu, Natallia Varankovich, Daniel He, Travis M Blimkie, Amy H Lee, Erin E Gill, Mark Novotny, Brian Aevermann and 36 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Pharmacogenomics and Vaccine Development.Clinical pharmacology and therapeutics · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors at 16 institutions in 4 countries.

Rym Ben-OthmanVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Bing CaiVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Aaron C LiuVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Natallia VarankovichVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Daniel HeVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Travis M BlimkieCentre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, BC, Canada.
Amy H LeeSimon Fraser University, Burnaby, BC, Canada.
Erin E GillCentre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, BC, Canada.
Mark NovotnyDepartment of Informatics, J. Craig Venter Institute (La Jolla), La Jolla, CA, United States.
Brian AevermannDepartment of Informatics, J. Craig Venter Institute (La Jolla), La Jolla, CA, United States.
Sibyl DrisslerTerry Fox Laboratory, Vancouver, BC, Canada.
Casey P ShannonPrevention of Organ Failure (PROOF) Centre of Excellence and Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
Sarah McCannVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Kim MartyVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Gordean BjornsonVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Rachel D EdgarCentre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
David Tse Shen LinCentre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Nicole GladishCentre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Julia MaclsaacCentre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Nelly AmenyogbeTelethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
Queenie ChanDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Alba LlibreTranslational Immunology Lab, Institut Pasteur, Paris, France.
Joyce CollinDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, United States.
Elise LandaisDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, United States.
Khoa LeDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, United States.
Samantha M ReissCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, United States.
Wayne C KoffHuman Vaccines Project, New York, NY, United States.
Colin Havenar-DaughtonCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, United States.
Manraj HeranDepartment of Radiology, BC Children's Hospital, Vancouver, BC, Canada.
Bippan SanghaDepartment of Radiology, BC Children's Hospital, Vancouver, BC, Canada.
David WaltWyss Institute at Harvard University, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Mel KrajdenBritish Columbia Centre for Disease Control, Vancouver, BC, Canada.
Shane CrottyCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, United States.
Devin SokDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, United States.
Bryan BrineyDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, United States.
Dennis R BurtonDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, United States.
Darragh DuffyTranslational Immunology Lab, Institut Pasteur, Paris, France.
Leonard J FosterDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
William W MohnDepartment of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.
Michael S KoborCentre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Scott J TebbuttPrevention of Organ Failure (PROOF) Centre of Excellence and Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
Ryan R BrinkmanTerry Fox Laboratory, Vancouver, BC, Canada.
Richard H ScheuermannDepartment of Informatics, J. Craig Venter Institute (La Jolla), La Jolla, CA, United States.
Robert E W HancockCentre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, BC, Canada.
Tobias R KollmannVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Manish SadaranganiVaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
University of British Columbia · CABC Children's Hospital · CAScripps Research Institute · USJ. Craig Venter Institute · USLa Jolla Institute for Immunology · USInstitut Pasteur · FRThe Kids Research Institute Australia · AUBC Centre for Disease Control · CABrigham and Women's Hospital · USHuman Immunome Project · USInternational AIDS Vaccine Initiative · USPrevention of Organ Failure · CASimon Fraser University · CASt. Paul's Hospital · CATerry Fox Research Institute · CAThe University of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional vaccine design has been based on trial-and-error approaches, which have been generally successful. However, there have been some major failures in vaccine development and we still do not have highly effective licensed vaccines for tuberculosis, HIV, respiratory syncytial virus, and other major infections of global significance. Approaches at rational vaccine design have been limited by our understanding of the immune response to vaccination at the molecular level. Tools now exist to undertake in-depth analysis using systems biology approaches, but to be fully realized, studies are required in humans with intensive blood and tissue sampling. Methods that support this intensive sampling need to be developed and validated as feasible. To this end, we describe here a detailed approach that was applied in a study of 15 healthy adults, who were immunized with hepatitis B vaccine. Sampling included ~350 mL of blood, 12 microbiome samples, and lymph node fine needle aspirates obtained over a ~7-month period, enabling comprehensive analysis of the immune response at the molecular level, including single cell and tissue sample analysis. Samples were collected for analysis of immune phenotyping, whole blood and single cell gene expression, proteomics, lipidomics, epigenetics, whole blood response to key immune stimuli, cytokine responses,

Indexed as

AdultAgedAged, 80 and overFemaleHepatitis BHepatitis B VaccinesHepatitis B virusHumansMaleMiddle AgedMonitoring, ImmunologicProspective StudiesSystems BiologyTreatment OutcomeVaccinationHepatitis B Vaccinesbio-informaticgene expressionimmunimonitoringlymph nodemulti-omicsingle cellvaccine

Identifiers

PMID33250895
PMCPMC7672042
OpenAlexW3095202544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.